Group 1 - Tianzhihang Medical Technology Co., Ltd. focuses on the research, production, sales, and service of orthopedic surgical navigation robots, with a revenue composition of 58.31% from navigation robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1] - As of January 5, Tianzhihang's stock price increased by 5% to 15.95 CNY per share, with a trading volume of 60.94 million CNY and a turnover rate of 0.85%, resulting in a total market capitalization of 7.273 billion CNY [1] Group 2 - E Fund's ETF, E Fund Guozheng Robotics Industry ETF (159530), entered Tianzhihang's top ten circulating shareholders in the third quarter, holding 10.78 million shares, which is 2.38% of the circulating shares, with an estimated floating profit of approximately 8.1931 million CNY [2] - The E Fund Guozheng Robotics Industry ETF has a current scale of 13.315 billion CNY and has achieved a year-to-date return of 36.58%, ranking 1266 out of 4189 in its category [2] Group 3 - The fund managers of E Fund Guozheng Robotics Industry ETF are Li Shujian and Li Xu, with total fund assets of 19.758 billion CNY and 26.538 billion CNY respectively [3] - Li Shujian has a tenure of 2 years and 120 days, with the best fund return of 114.87% and the worst return of -6.47% during his tenure [3] - Li Xu has a tenure of 3 years and 42 days, with the best fund return of 139.24% and the worst return of -5.57% during his tenure [3]
天智航股价涨5%,易方达基金旗下1只基金位居十大流通股东,持有1078.03万股浮盈赚取819.31万元